Skip to content
Go to target 3.a: Implement the WHO framework convention on tobacco control Go to target 3.a
Target 3.b: Target 3.b

Target 3.b

Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.

Go to target 3.c Go to target 3.c: Increase health financing and support health workforce in developing countries

Indicators

3.b.1

3.b.2 3.b.3
Proportion of the target population covered by all vaccines (per cent)
Area: Total  |  Unit: Per cent
Unit: Per cent
2008200920102011201220132014201520162017201820192020202120222023
Diphtheria, tetanus and pertussis (DTP)89899089919191959595949595969696
Measles90909190909191919191919394......
Pneumococcal conjugate vaccine (PCV)87888888898990949594949495959696
Human Papillomavirus (HPV)8180808178......................

Download data

Definition

Data is derived from the homepage www.statistik.ssi.dk. The recorded information pertains to children from the birth cohort that, according to the Danish vaccination program, should have received their final scheduled vaccination. This means that the figures show how many rom a given birth cohort have received the last dose of a specific vaccine within the program.

Last updated:

18-11-2025